Supporting the

Neuroendocrine Cancer Community

Neuroendocrine Cancer UK turns 21

Jun 11, 2023

Today is a momentous day for Neuroendocrine Cancer UK as our organisation reaches a significant milestone—turning 21!

Over two decades ago, our journey began with a humble helpline operating from Catherine’s kitchen table. Today, we stand tall as a beacon of support for thousands of patients and their families across the UK who are affected by neuroendocrine cancer.

We want to express our deepest gratitude to our CEO, Catherine Bouvier, who has been our organisation’s driving force from the beginning. Alongside co-founders, Peter Gwilliam, Liddy Oldroyd, Andy Geach, and Cathy Kalamis, Catherine’s visionary leadership has transformed their dream of making a difference into a reality.

In honour of this remarkable milestone, Catherine has recorded a heartfelt video that takes us on a reflective journey through the past 21 years. Her words beautifully capture the passion, dedication, and unwavering commitment that has propelled Neuroendocrine Cancer UK to where we stand today.


Nevertheless, we must acknowledge that much work still needs to be done. In an ideal world, our existence would not be necessary. Unfortunately, the harsh reality is that neuroendocrine cancer continues to affect the lives of countless individuals. Our unwavering promise is to strive to continue to support anyone impacted by this disease.

So today, we invite you to give an enormous shoutout to EVERYONE who has supported Neuroendocrine Cancer UK over the last 21 years. Your unwavering support, advocacy, and efforts have been instrumental in our journey.

Together, we can create a meaningful difference and continue improving the lives of those diagnosed and living with the 10th most prevalent cancer in England, neuroendocrine cancer.